Home > Journals > Minerva Pediatrica > Past Issues > Articles online first > Minerva Pediatrica 2016 May 27





A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry

Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,532



Minerva Pediatrica 2016 May 27

language: English

Recent advances in delivery mechanisms for aerosol therapy during pediatric respiratory diseases

Yue’E WU, Chonglin ZHANG, Qing CHEN

Department of Respiration, Xuzhou Children's Hospital


The treatment of pediatric surgery diseases via utilization of aerosol delivery mechanisms is in progress for the betterment of pediatric care. Over the years, aerosol therapy has come to play an integral role in the treatment of pediatric respiratory diseases. Inhaled aerosol agents such as bronchodilators, corticosteroids, antibiotics, and mucolytics are commonly delivered to spontaneously breathing pediatric patients with a tracheostomy. Administering therapeutic inhaled aerosols to pediatric patients is challenging. The pediatric population ranges in age, which means patients with different airway sizes, breathing patterns, and cooperation levels. These patient-related factors impact the deposition of aerosol drugs in the lungs. The present review article will discuss the recent advancements in the delivery mechanisms for aerosol therapy in pediatric patients with respiratory diseases.

top of page

Publication History

Cite this article as

Corresponding author e-mail